The UHLG Breast research team are proud to celebrate the outstanding dedication and hard work within research.
The team has exceeded recruitment targets across all studies and remain one of the top recruiting teams nationally—a truly remarkable and ongoing achievement.
To take part in a research study please contact the team.
A double-blinded study to evaluate how effective lidocaine infusions are to treat chronic post-surgical pain (CPSP), when given during surgery and extending up to 24 hours post-surgery, in those who are undergoing breast cancer surgery
This trial is for patients aged 18 and over who are undergoing a mastectomy or breast conserving surgery (one or both breasts), for the primary excision of confirmed or suspected breast cancer under general anaesthesia
Open Surgery versus Minimally invasive vacuum-Assisted excision for smaLL screen-detected breast Cancer.
This trial aims to determine whether the extent of surgical treatment for early screen-detected biologically favourable breast cancer can be reduced.
- Women aged 47 and over
- <15mm maximum tumour diameter on screen-detected mammogram and ultrasound
- No associated malignant microcalcification outwith the mass lesion (within is permitted)
Reducing ethnic inequalities for Black women with breast cancer: the role of treatment uptake, engagement and support.
This trial explore how societal or health system factors impact on someone’s motivation and ability to engage with their ET treatment, and whether key predictors of adherence may differ in different ethnic groups.
Understanding side effects experienced by women prescribed hormone therapy.
This trial aims to investigate the influence of AET brand changes on adherence and AEs in those patients’ receiving treatment for breast cancer.
This study will test whether a new medicine, fezolinetant, can safely and effectively reduce troublesome hot flushes in women with breast cancer who are taking hormone therapy. It compares the medicine with a placebo to see how well it works and how safe it is.
